Blood Cancer Information

In this section you will find disease specific information on the main types of blood cancers and allied blood disorders.

Leukaemia

Leukaemia is a cancer which starts in blood-forming tissue, usually the bone marrow. It leads to the over-production of abnormal white blood cells, the part of the immune system which defends the body against infection.

Signs and symptoms of leukaemia

Leukaemia can be hard to spot because the signs and symptoms are common to other unrelated illnesses. Knowing what to look out for could help you make the decision to visit your GP sooner for a blood test.

Leukaemia Myths

There are many myths about leukaemia. Get yourself clued up with the following guide

Lymphoma

Lymphoma is cancer that starts in the lymph glands or other organs of the lymphatic system. The lymphatic system is a network of fine vessels, glands and channels which occur throughout the body.

Myeloma

Myeloma, also known as multiple myeloma, is a cancer of the bone marrow which affects the plasma cells, a type of blood cell.

Aplastic Anaemia

Aplastic anaemia (AA) is a rare condition in which the bone marrow fails produce all three major types of blood cell. It is not a form of cancer.

Myeloproliferative neoplasms (MPN)

Myeloproliferative neoplasms, also known as myeloproliferative disorders (MPDs) are a group of conditions that are closely related to leukaemia.

Myelodysplastic syndromes (MDS)

Myelodysplastic syndromes (MDS) are a group of diseases where the production of blood cells by the bone marrow is disrupted.

Left to #WatchWaitWorry resources

Support our campaign and download our #WatchWaitWorry graphics below.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

June 30th

5 things you need know about today’s new drug approval for CML patients

We are pleased to announce a new treatment, asciminib, has been approved for NHS use in chronic myeloid leukaemia (CML) patients after 2 or more tyrosine kinase inhibitors (TKIs)....

June 30th

Leukaemia Care successfully campaigns for new leukaemia treatment on behalf of CML patients

Leukaemia Care successfully campaigns for the National Institute for Health and Care Excellence (NICE) to approve asciminib on the NHS in England for chronic myeloid leukaemia (CML) patients after 2 or more tyrosine kinase inhibitors (TKIs). ...

June 23rd

5 reasons why you should attend our hybrid community gathering

Join our biggest community gathering virtually or in-person on Saturday 13th August 2022....